These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9816098

  • 1. Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines.
    Cerutti J, Trapasso F, Battaglia C, Zhang L, Martelli ML, Visconti R, Berlingieri MT, Fagin JA, Santoro M, Fusco A.
    Clin Cancer Res; 1996 Jan; 2(1):119-26. PubMed ID: 9816098
    [Abstract] [Full Text] [Related]

  • 2. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression.
    Visconti R, Cerutti J, Battista S, Fedele M, Trapasso F, Zeki K, Miano MP, de Nigris F, Casalino L, Curcio F, Santoro M, Fusco A.
    Oncogene; 1997 Oct 16; 15(16):1987-94. PubMed ID: 9365245
    [Abstract] [Full Text] [Related]

  • 3. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
    Robinson LA, Smith LJ, Fontaine MP, Kay HD, Mountjoy CP, Pirruccello SJ.
    Ann Thorac Surg; 1995 Dec 16; 60(6):1583-91. PubMed ID: 8787447
    [Abstract] [Full Text] [Related]

  • 4. Phosphorothioated antisense c-myc oligonucleotide inhibits the growth of human colon carcinoma cells.
    Yu BW, Nguyen D, Anderson S, Allegra CA.
    Anticancer Res; 1997 Dec 16; 17(6D):4407-13. PubMed ID: 9494542
    [Abstract] [Full Text] [Related]

  • 5. Oncogenes and growth factors in thyroid carcinogenesis.
    Frauman AG, Moses AC.
    Endocrinol Metab Clin North Am; 1990 Sep 16; 19(3):479-93. PubMed ID: 2175702
    [Abstract] [Full Text] [Related]

  • 6. Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines.
    Van Waardenburg RC, Prins J, Meijer C, Uges DR, De Vries EG, Mulder NH.
    Anticancer Res; 1996 Sep 16; 16(4A):1963-70. PubMed ID: 8712728
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Inhibition of c-sis protein synthesis and cell growth with antisense oligonucleotides in human glioma cells].
    Nitta T, Sato K.
    No Shinkei Geka; 1992 Aug 16; 20(8):857-63. PubMed ID: 1508312
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Expression, amplification and rearrangement of c-myc gene in human thyroid carcinoma].
    Yang Y.
    Zhonghua Yi Xue Za Zhi; 1991 Jun 16; 71(6):304-6, 22. PubMed ID: 1667490
    [Abstract] [Full Text] [Related]

  • 11. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F, Brignole C, Marimpietri D, Di Paolo D, Zancolli M, Pagnan G, Ponzoni M.
    Ann N Y Acad Sci; 2004 Dec 16; 1028():90-103. PubMed ID: 15650235
    [Abstract] [Full Text] [Related]

  • 12. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines.
    van Waardenburg RC, Meijer C, Pinto-Sietsma SJ, de Vries EG, Timens W, Mulder NM.
    Anticancer Res; 1998 Dec 16; 18(1A):91-5. PubMed ID: 9568061
    [Abstract] [Full Text] [Related]

  • 13. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
    Chavany C, Connell Y, Neckers L.
    Mol Pharmacol; 1995 Oct 16; 48(4):738-46. PubMed ID: 7476902
    [Abstract] [Full Text] [Related]

  • 14. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
    Leonetti C, Biroccio A, Candiloro A, Citro G, Fornari C, Mottolese M, Del Bufalo D, Zupi G.
    Clin Cancer Res; 1999 Sep 16; 5(9):2588-95. PubMed ID: 10499637
    [Abstract] [Full Text] [Related]

  • 15. CD40 stimulation inhibits cell growth and Fas-mediated apoptosis in a thyroid cancer cell line.
    Fujieda S, Sugimoto C, Seki M, Sunaga H, Saito H.
    Oncol Res; 1998 Sep 16; 10(9):433-9. PubMed ID: 10223618
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of epidermal growth factor and fetal calf serum in human endometrial carcinoma RL95-2 cells.
    Sallot M, Lascombe I, Bermont L, Jouvenot M.
    Anticancer Res; 1997 Sep 16; 17(5A):3499-504. PubMed ID: 9413194
    [Abstract] [Full Text] [Related]

  • 17. c-myc antisense oligonucleotides inhibit the colony-forming capacity of Colo 320 colonic carcinoma cells.
    Collins JF, Herman P, Schuch C, Bagby GC.
    J Clin Invest; 1992 May 16; 89(5):1523-7. PubMed ID: 1569190
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line.
    Yasuoka Y, Naomoto Y, Yamatsuji T, Takaoka M, Kimura M, Uetsuka H, Matsubara N, Fujiwara T, Gunduz M, Tanaka N, Haisa M.
    Exp Cell Res; 2001 Dec 10; 271(2):214-22. PubMed ID: 11716533
    [Abstract] [Full Text] [Related]

  • 20. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.
    Belletti B, Ferraro P, Arra C, Baldassarre G, Bruni P, Staibano S, De Rosa G, Salvatore G, Fusco A, Persico MG, Viglietto G.
    Oncogene; 1999 Aug 26; 18(34):4860-9. PubMed ID: 10490819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.